Blume Capital Management, Inc. Viatris Inc Transaction History
Blume Capital Management, Inc.
- $432 Million
- Q3 2024
A detailed history of Blume Capital Management, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Blume Capital Management, Inc. holds 19 shares of VTRS stock, worth $203. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 19
-0.0%
Holding current value
$203
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding VTRS
# of Institutions
1,106Shares Held
967MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.51 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$994 Million0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$677 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$671 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$523 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...